TP53 and cancer: To complicate this picture even more, we showed that in SKBR3 cells the endogenous level of MDM2 was sufficient for the formation of a p53 R175H-TAp73α-MDM2 complex, which inhibited TAp73α-dependent apoptosis of SKBR3 cancer cells [39].